InvestorsHub Logo
Post# of 890
Next 10
Followers 481
Posts 60441
Boards Moderated 18
Alias Born 09/20/2001

Re: CogDiss 1188X post# 577

Saturday, 07/04/2020 12:06:10 AM

Saturday, July 04, 2020 12:06:10 AM

Post# of 890
But the NIH is still collaborating with Novartis:


NIH has formed a partnership with 16 drug companies to accelerate the development of coronavirus treatments. The partners have committed to standardizing their preclinical evaluations openly to enable comparison and validation. AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Evotec, GlaxoSmithKline, Johnson & Johnson, KSQ Therapeutics, Eli Lilly, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda and Vir Biotechnology have agreed to be part of the partnership.

Novartis said it will soon begin enrolling patients in a phase 3 clinical trial evaluating hydroxychloroquine in hospitalized COVID-19 patients. The large trial will include more than 440 patients across more than a dozen U.S. trial sites.



https://www.centerwatch.com/articles/24664-covid-19-update


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.